196. The TGA says the vaccines are provisional to last sometime in 2023 or 2024. How are they compiling their data when not all doctors, hospitals, medical industry etc are not even notifying the TGA, ATAGI, CDC, FDA, NIH of adverse events. How does the TGA retrieve information and statistics from so they can form a conclusion if it works or not? 216. Was testing performed on vaccines that were given after their initial expiry date to ensure their safety? If not, why not?

Question Number: 221 PDR Number: SQ22-000591 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 196 Conditions of provisional registration for all COVID-19 vaccines in Australia also require the submission of study reports to collect confirmatory safety and efficacy data. These requirements are listed in the Australian Public Assessment Report for each vaccine and […]

114. If the vaccine can transfer the antibodies through the mother’s milk then why can’t the vaccine transfer spike protein through the mothers milk? What studies were carried out to prove that spike proteins couldn’t be transferred through the mothers milk?

Question Number: 220 PDR Number: SQ22-000590 Date Submitted: 21/11/2022 Department or Body: Department of Health Reproductive toxicity studies in rats vaccinated with high doses of the Pfizer or Moderna COVID-19 vaccine before mating and during gestation showed no adverse effects in dams or pups. Recent reports have shown that breastfeeding people who have received mRNA […]

200. Who is responsible for acting on the safety signal in the DAEN database re Covid vaccines – the TGA or the sponsor? 214. I note that the Covid vaccines were provisionally approved subject to strict reporting conditions on safety and efficacy. Since provisional approval what has Pfizer reported to the TGA in regards to safety and efficacy since the rollout of the vaccine? 215. Can the safety reports provided by the Covid vaccine sponsors please be provided? 266. “The TGA’s vaccine safety monitoring system can rapidly detect, investigate and respond to any emerging safety issues identified for COVID-19 vaccines.” The TGA’s monitoring system is passive and therefore it can never “rapidly detect” safety issues! These pages are misleading the public are they not? https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccineapproval-process

Question Number: 219 PDR Number: SQ22-000589 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 200 Both the Therapeutic Goods Administration (TGA) and pharmaceutical sponsors undertake pharmacovigilance, which is the science of identification, investigation, and action to address emerging safety issues for a medicine or vaccine. Analysis of adverse event reporting data is used […]

211. How much has the Federal government spent on advertising the Covid vaccines? 212. How much has the Federal government spent on advertising Covid measures?

Question Number: 216 PDR Number: SQ22-000586 Date Submitted: 21/11/2022 Department or Body: Department of Health Since the start of the pandemic in 2020 to 31 October 2022, the Department of Health and Aged care has expended $107.535 million (excluding GST) on advertising to inform the community on how to protect themselves from COVID-19 including through […]

112. PCR testing – if it can’t distinguish between live and dead virus how why can the Health Department say it’s the gold standard? How many false positives were reported – one study says as many as 43% – does the Health department have any idea? 113. Is it possible that positive PCR tests were actually just a strain of the influenza virus? There was a marked decrease in influenza throughout the Covid pandemic.

Question Number: 215 PDR Number: SQ22-000585 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 112 COVID-19 PCR tests are designed to look for and then amplify a target region of the viral genome which is specific to the SARS-CoV-2 virus. This means that a PCR test result may be positive for COVID-19 after […]

206. How many people who died from Covid were given Remdesivir? 207. Why did the TGA approve Remdesivir on next to no evidence when it was still being trialled and the WHO recommended against it?

Question Number: 214 PDR Number: SQ22-000584 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 206 The Therapeutic Goods Administration (TGA) does not hold medical treatment information on patients in Australia who have died from COVID-19. The TGA may receive adverse event reports relating to a specific treatment given to a patient. Question 207 […]

111. Did anyone on the vaccine approval committee, including the Advisory Committee on Medicines Scheduling (ACMS) ever receive money either directly or indirectly from the organisations who make vaccines?

Question Number: 213 PDR Number: SQ22-000583 Date Submitted: 21/11/2022 Department or Body: Department of Health The statutory advisory committee that provides advice to the Therapeutic Goods Administration (TGA) on vaccines is the Advisory Committee on Vaccines (ACV). Neither the ACV and Advisory Committee on Medicines Scheduling (ACMS) approve vaccines, and the latter committee does not […]

184. Can the TGA provide a breakout of its revenue stream by organisation? 205. Leaked emails from the EMA show they lodged a Major objection with Pfizer, namely that the possibility of translated proteins other than the translated protein resulting from truncated or modified mRNA should be addressed. Were these concerns addressed? The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns – Health Policy Watch (healthpolicy-watch.news)

Question Number: 211 PDR Number: SQ22-000581 Date Submitted: 21/11/2022 Department or Body: Department of Health Question 184 In 2021-22, the Therapeutic Goods Administration (TGA) collected $173.9 million fees and charges revenue from 5,755 organisations. Question 205 The TGA is aware that a cyberattack on the European Medicines Agency (EMA) resulted in unlawfully accessed documents, related […]

204. Studies have shown that the weight of the protein produced by the mRNA vary by as much as 50% – surely this is evidence that the mRNA is not being produced in a consistent manner by the ribosomes? Is the TGA tracking the product being produced by the ribosomes? 221. Why is TGA/Pfizer calling it mRNA when it isn’t mRNA – the use of Methylpseudouridine means it’s a different substance does it not? 267. Which part of the mRNA code directs it to be processed on the ribosomes bound to the endoplasmic reticulum – could the TGA please state the name of the amino acid and what position the amino acid sits on the mRNA strand? 289. Is pseudouridine impervious to the mRNAse, the enzyme that breaks down mRNA?

Question Number: 210 PDR Number: SQ22-000580 Date Submitted: 21/11/2022 Department or Body: Department of Health 204 A variation of 50% would not be accepted by the Therapeutic Goods Administration (TGA) and is not. The results of the in vitro translation test (i.e. protein production by translated vaccine mRNA) are monitored through the TGA batch release […]

109. Can all conflicts of interests between ATAGI members and pharmaceutical companies whether directly or indirectly through universities they work for please be provided. Could he amount of payment, purpose of payment and the payer be disclosed? 110. Why are people allowed to sit on ATAGI if they have conflicts of interest?

Question Number: 209 PDR Number: SQ22-000579 Date Submitted: 21/11/2022 Department or Body: Department of Health Response previously provided in SQ22-000148 outlines how conflicts of interest are managed.